IP Library Granted Patent US 12,521,038
Granted Patent B2
US 12,521,038 · App. 16/805,038 · Granted Jan 13, 2026

Method and apparatus for detecting and treating heart failure

Inventors: Klaus Henry Schindhelm (Sydney, AU); Ian Wilcox (Dawes Point, AU); Rachel Ann Coxon (Rosehill, AU)
Assignee: ResMed Pty Ltd
A61B5/0826A61B5/0816A61B5/0873A61B5/14552A61B8/08A61M16/0003G16H40/63G16H50/20A61M2016/0033A61M2205/3303
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,038
App. No.
16/805,038
Granted
Jan 13, 2026
Kind
B2
Abstract

Devices and systems provide methods of detecting a heart failure condition of a patient that may be based on one or more respiratory parameters of a patient. In an example embodiment, a monitoring device determines one or more heart failure condition indicators based on a measure of the patient respiratory airflow and/or a measure of treatment pressure. Respiratory parameters such as respiration rate, hypopneas, apneas, Cheyne-Stokes breathing patterns or apnea-hypopnea counts may be compared to thresholds that are selected to represent a change in the condition of a heart failure patient such as an onset of a decompensation event. Results of the comparisons may trigger a pressure treatment change and/or one or more warnings or messages to notify a patient or physician of a pending change to the patient's heart failure condition so that the patient may more immediately seek medical attention to treat the heart failure condition.

Claims (45)

1 . An apparatus comprising a controller for evaluating a heart failure condition of a patient during respiratory pressure treatment, the apparatus comprising:

a plurality of sensors comprising a sensor configured measure treatment pressure delivered by a respiratory treatment device, the plurality of sensors further comprising a photoplethysmogram sensor; and

a processor coupled with the plurality of sensors, the processor configured to:

control a determination of a heart failure condition change indicator based on i) an event comprising detection of a first trend and ii) an index of arterial stiffness determined with the photoplethysmogram sensor, wherein the first trend comprises a trend of increases in treatment pressure and, wherein the trend of increases is a period of two or more days, the indicator representing information about a change in a heart failure condition of the patient,

generate a decompensation warning in response to the determination of the heart failure condition change indicator, wherein the decompensation warning is generated based on prior decompensation warnings, and

control a change to the respiratory pressure treatment delivered by the respiratory treatment device in response to the heart failure condition change indicator.

2 . The apparatus of claim 1 , wherein the processor is configured to determine a measure of respiration of the patient with data from a sensor of the plurality of sensors; and

wherein the processor is configured to determine the heart failure condition change indicator further based on the measure of respiration.

3 . The apparatus of claim 2 , wherein the processor implements a threshold comparison that detects an increase in a proportion of the measure of treatment pressure and an increase in an apnea or Apnea-Hypopnea Index (AHI) count during a common time period.

4 . The apparatus of claim 1 , further comprising a flow generator coupled with the processor.

5 . The apparatus of claim 4 , wherein the change to the respiratory pressure treatment comprises initiating control of ventilation support to meet a target ventilation.

6 . The apparatus of claim 1 , wherein the trend includes one or more pressure measures from prior treatment sessions.

7 . The apparatus of claim 1 , wherein the plurality of sensors are further configured to sense one or more patient characteristics, and wherein the determination of the heart failure condition change indicator is further based on the sensed one or more patient characteristics.

8 . The apparatus of claim 7 , wherein the plurality of sensors further comprises a sensor configured as a non-contact sensor.

9 . The apparatus of claim 8 , wherein the non-contact sensor is configured to detect respiratory parameters from a signal measured by the non-contact sensor.

10 . The apparatus of claim 9 , wherein the non-contact sensor is configured to monitor sound.

11 . The apparatus of claim 10 , wherein the non-contact sensor comprises an ultrasonic sensor.

12 . The apparatus of claim 11 , wherein the non-contact sensor comprises an ultrasonic screening sensor.

13 . The apparatus of claim 7 , wherein the plurality of sensors comprises a movement sensor configured to generate a movement signal indicative of patient respiration.

14 . The apparatus of claim 7 , wherein a sensor of the plurality of sensors is configured to transmit data to a controller of the respiratory treatment device and wherein the respiratory treatment device comprises a servo-controlled blower.

15 . The apparatus of claim 1 , wherein the event comprises detection, during a similar time period, of the first trend and a second trend, wherein the second trend comprises a trend of increases in obstructive breathing events.

16 . The apparatus of claim 1 , wherein the determination of the heart failure condition change indicator is further based on measures of at least one of i) heart rate, ii) blood pressure, or iii) blood-oxygen levels.

17 . The apparatus of claim 1 , wherein the determined heart failure condition change indicator is based on a comparison of the index of arterial stiffness and a threshold.

18 . A method for evaluating a heart failure condition of a patient during respiratory pressure treatment comprising:

determining a measure of treatment pressure delivered by a respiratory treatment apparatus with a sensor;

determining an index of arterial stiffness with a photoplethysmogram sensor;

determining a heart failure condition change indicator with a processor based on i) an event comprising detection of a first trend and ii) the index of arterial stiffness, wherein the first trend comprises a trend of increases in treatment pressure, wherein the trend is a period of two or more days, the indicator representing information about a change in a heart failure condition of the patient;

generating a decompensation warning in response to the determination of the heart failure condition change indicator, wherein the decompensation warning is generated based on prior decompensation warnings; and

controlling, by the processor, a change to the respiratory pressure treatment of the respiratory treatment apparatus in response to the heart failure condition change indicator.

19 . The method of claim 18 , further comprising:

determining a measure of respiration of the patient with a sensor; and

wherein the determining of the heart failure condition change indicator is further based on the measure of respiration.

20 . The method of claim 19 , wherein the determining of the heart failure condition change indicator comprises a threshold comparison that detects an increase in a proportion of the measure of treatment pressure and an increase in an Apnea-Hypopnea Index (AHI) or apnea count during a common time period.

21 . The method of claim 18 , wherein the change to the respiratory pressure treatment comprises initiating control of ventilation support to meet a target ventilation.

22 . The method of claim 18 , wherein the trend includes one or more pressure measures from prior treatment sessions.

23 . The method of claim 18 , further comprising sensing with one or more sensors configured to sense one or more patient characteristics, and wherein the determining of the heart failure condition change indicator is further based on the sensed one or more patient characteristics.

24 . The method of claim 23 , wherein the one or more sensors comprises a sensor configured for non-contact sensing.

25 . The method of claim 24 , wherein the sensor configured for non-contact sensing is configured to detect respiratory parameters from a signal measured by the sensor configured for non-contact sensing.

26 . The method of claim 25 , wherein the sensor configured for non-contact sensing is configured to monitor sound.

27 . The method of claim 26 , wherein the sensor configured for non-contact sensing comprises an ultrasonic sensor.

28 . The method of claim 27 , wherein the sensor configured for non-contact sensing comprises an ultrasonic screening sensor.

29 . The method of claim 23 , wherein the one or more sensors comprises a movement sensor configured to generate a movement signal indicative of patient respiration.

30 . The method of claim 23 , wherein the one or more sensors are configured to transmit data to a controller of the respiratory treatment apparatus, wherein the respiratory treatment apparatus comprises a servo-controlled blower.

31 . The method of claim 18 , wherein the event comprises detection, during a similar time period, of the first trend and a second trend, wherein the second trend comprises a trend of increases in obstructive breathing events.

32 . The method of claim 18 , wherein the determining of the heart failure condition change indicator comprises a comparison of the index of arterial stiffness and a threshold.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2020
From: WILCOX, IAN; SCHINDHELM, KLAUS HENRY; COXON, RACHEL ANN
To: RESMED LIMITED
Reel/Frame 052664/0346 →
CHANGE OF NAME Recorded May 14, 2020
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 052666/0381 →
Continuity (4)
Continuation 14469866 · Aug 27, 2014
Continuation 12483357 · Jun 12, 2009
Provisional Application 61083596 · Jul 25, 2008
Related Publication 20200268279A1 · Aug 27, 2020
References Cited (75)
US 4519399A · Hori · 1985 [cited by applicant]
US 4958638A · Sharpe et al. · 1990 [cited by applicant]
US 5020516A · Biondi et al. · 1991 [cited by applicant]
US 5188098A · Hoffman et al. · 1993 [cited by applicant]
US 5259373A · Gruenke et al. · 1993 [cited by applicant]
US 5353788A · Miles · 1994 [cited by applicant]
US 5535738A · Estes et al. · 1996 [cited by applicant]
US 5584290A · Brain · 1996 [cited by applicant]
US 5704345A · Berthon-Jones · 1998 [cited by applicant]
US 5740797A · Dickson · 1998 [cited by applicant]
US 5794615A · Estes · 1998 [cited by applicant]
US 5846720A · Foulkes et al. · 1998 [cited by applicant]
US 6062216A · Corn · 2000 [cited by applicant]
US 6105575A · Estes et al. · 2000 [cited by applicant]
US 6308706B1 · Lammers · 2001 [cited by examiner]
US 6467477B1 · Frank · 2002 [cited by examiner]
US 7100608B2 · Brewer et al. · 2006 [cited by applicant]
US 7210478B2 · Banner et al. · 2007 [cited by applicant]
US 7272431B2 · McGrath · 2007 [cited by applicant]
US 7398115B2 · Lynn · 2008 [cited by applicant]
US 7575005B2 · Mumford et al. · 2009 [cited by applicant]
US 8251061B2 · Lee et al. · 2012 [cited by applicant]
US 8454528B2 · Yuen et al. · 2013 [cited by applicant]
US 20020088465A1 · Hill · 2002 [cited by applicant]
US 20020169384A1 · Kowallik et al. · 2002 [cited by applicant]
US 20030036685A1 · Goodman · 2003 [cited by examiner]
US 20030055491A1 · Schwartz · 2003 [cited by examiner]
US 20030078619A1 · Bonnet et al. · 2003 [cited by applicant]
US 20030121519A1 · Estes et al. · 2003 [cited by applicant]
US 20030154979A1 · Berthon-Jones · 2003 [cited by applicant]
US 20040134496A1 · Cho et al. · 2004 [cited by applicant]
US 20040237963A1 · Berthon-Jones · 2004 [cited by applicant]
US 20050085734A1 · Tehrani · 2005 [cited by examiner]
US 20050121033A1 · Starr et al. · 2005 [cited by applicant]
US 20060084877A1 · Ujhazy · 2006 [cited by examiner]
US 20060241510A1 · Halperin et al. · 2006 [cited by applicant]
US 20070073168A1 · Zhang et al. · 2007 [cited by applicant]
US 20070073181A1 · Pu · 2007 [cited by applicant]
US 20070129643A1 · Kwok et al. · 2007 [cited by applicant]
US 20070135724A1 · Ujhazy et al. · 2007 [cited by applicant]
US 20070142732A1 · Brockway et al. · 2007 [cited by applicant]
US 20070239055A1 · Sowelam et al. · 2007 [cited by applicant]
US 20070293736A1 · Casset · 2007 [cited by examiner]
US 20080000475A1 · Hill · 2008 [cited by applicant]
US 20080058773A1 · John · 2008 [cited by examiner]
US 20080058873A1 · Lee · 2008 [cited by applicant]
US 20090203972A1 · Heneghan et al. · 2009 [cited by applicant]
US 20100018530A1 · Schindhelm et al. · 2010 [cited by applicant]
EP 1295623A1 · 2003 [cited by applicant]
GB 2294642A · 1996 [cited by applicant]
JP 06205762 · 1994 [cited by applicant]
JP 2000083927A · 2000 [cited by applicant]
JP 200258659A · 2002 [cited by applicant]
JP 2008099849A · 2008 [cited by applicant]
JP 2008515494A · 2008 [cited by applicant]
WO 1989009041A1 · 1989 [cited by applicant]
WO 199632055A1 · 1996 [cited by applicant]
WO 1997030744A1 · 1997 [cited by applicant]
WO 199852467A1 · 1998 [cited by applicant]
WO 9945989A1 · 1999 [cited by applicant]
WO 1999061088A1 · 1999 [cited by applicant]
WO 0045702A1 · 2000 [cited by applicant]
WO 2000045702A1 · 2000 [cited by applicant]
WO 0067827A1 · 2000 [cited by applicant]
WO 2000067827A1 · 2000 [cited by applicant]
WO 2002026283A2 · 2002 [cited by applicant]
WO 2005037355A1 · 2005 [cited by applicant]
WO 2006037184A1 · 2006 [cited by applicant]
WO 2006066337A1 · 2006 [cited by applicant]
WO 2007064682A1 · 2007 [cited by applicant]
WO 2007143535A2 · 2007 [cited by applicant]
Otsuka “Utility of Second Derivative of the Finger Photoplethysmogram for the Estimation of Risk of Coronary Heart Disease in the General Population”, Circ J 2006 (70) 304-310. (Year: 2006). [cited by examiner]
European Search Report, EP 09166164, dated Oct. 7, 2009. [cited by applicant]
Examination Report from Corresponding NZ Application No. 578601, dated Jul. 31, 2009. [cited by applicant]
JP Patent Application No. 2015-236266 Office Action dated Oct. 3, 2017. [cited by applicant]